People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Medaica Inc. | — | Other Health Care | Pre-Seed | $1.3M | $1.5M | 2021 |
| M3dicine Holdings Inc. | — | Biotechnology | Pre-Seed | $600K | $33.1M | 2018 |
Pablo Rivas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Pablo Rivas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| STEPHEN RANDALL | 2 | 5 |
| Mark Gretton | 1 | 1 |
| Clive Millington | 1 | 1 |
| Dan Gieschen | 1 | 1 |
| Nayyar Hussain | 1 | 1 |
| Munir Hussain | 1 | 1 |
| Shabbir Hussain | 1 | 1 |
| Shamile Hussain | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.